234 related articles for article (PubMed ID: 16365401)
1. alpha-Lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis.
Ha H; Lee JH; Kim HN; Kim HM; Kwak HB; Lee S; Kim HH; Lee ZH
J Immunol; 2006 Jan; 176(1):111-7. PubMed ID: 16365401
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
3. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.
Suda K; Udagawa N; Sato N; Takami M; Itoh K; Woo JT; Takahashi N; Nagai K
J Immunol; 2004 Feb; 172(4):2504-10. PubMed ID: 14764723
[TBL] [Abstract][Full Text] [Related]
4. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.
Kotake S; Udagawa N; Takahashi N; Matsuzaki K; Itoh K; Ishiyama S; Saito S; Inoue K; Kamatani N; Gillespie MT; Martin TJ; Suda T
J Clin Invest; 1999 May; 103(9):1345-52. PubMed ID: 10225978
[TBL] [Abstract][Full Text] [Related]
5. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 strongly inhibits human osteoclast formation.
Take I; Kobayashi Y; Yamamoto Y; Tsuboi H; Ochi T; Uematsu S; Okafuji N; Kurihara S; Udagawa N; Takahashi N
Endocrinology; 2005 Dec; 146(12):5204-14. PubMed ID: 16150915
[TBL] [Abstract][Full Text] [Related]
8. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL.
Tsujisawa T; Inoue H; Nishihara T
J Bone Miner Res; 2005 Jan; 20(1):15-22. PubMed ID: 15619665
[TBL] [Abstract][Full Text] [Related]
9. Magnolol Inhibits Osteoclast Differentiation via Suppression of RANKL Expression.
Hwang YH; Kim T; Kim R; Ha H
Molecules; 2018 Jul; 23(7):. PubMed ID: 30004401
[TBL] [Abstract][Full Text] [Related]
10. Aminothiazoles inhibit osteoclastogenesis and PGE
Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
[TBL] [Abstract][Full Text] [Related]
11. Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells.
Nukaga J; Kobayashi M; Shinki T; Song H; Takada T; Takiguchi T; Kamijo R; Hasegawa K
J Periodontol; 2004 Feb; 75(2):249-59. PubMed ID: 15068113
[TBL] [Abstract][Full Text] [Related]
12. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
Hsieh TP; Sheu SY; Sun JS; Chen MH
Phytomedicine; 2011 Jan; 18(2-3):176-85. PubMed ID: 20554188
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.
Tai H; Miyaura C; Pilbeam CC; Tamura T; Ohsugi Y; Koishihara Y; Kubodera N; Kawaguchi H; Raisz LG; Suda T
Endocrinology; 1997 Jun; 138(6):2372-9. PubMed ID: 9165025
[TBL] [Abstract][Full Text] [Related]
14. IL-1-induced receptor activator of NF-kappa B ligand in human periodontal ligament cells involves ERK-dependent PGE2 production.
Fukushima H; Jimi E; Okamoto F; Motokawa W; Okabe K
Bone; 2005 Feb; 36(2):267-75. PubMed ID: 15780952
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
Lader CS; Flanagan AM
Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
[TBL] [Abstract][Full Text] [Related]
16. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA suppresses inflammatory bone loss by inhibiting the synthesis of prostaglandin E2 in osteoblasts.
Kwak HB; Sun HM; Ha H; Kim HN; Lee JH; Kim HH; Shin HI; Lee ZH
Eur J Pharmacol; 2008 Dec; 601(1-3):30-7. PubMed ID: 18973753
[TBL] [Abstract][Full Text] [Related]
18. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
19. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
[TBL] [Abstract][Full Text] [Related]
20. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
Huh JE; Jung IT; Choi J; Baek YH; Lee JD; Park DS; Choi DY
Eur J Pharmacol; 2013 Jan; 698(1-3):57-66. PubMed ID: 22985747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]